Find uplifting stories about heroes, innovations, and solutions
733 results for "hunter syndrome"
Families affected by Hunter syndrome now have hope as the FDA approves Avlayah, the first treatment designed to replace a missing enzyme that causes dangerous sugar buildup in the brain. This breakthrough marks a major victory for patients with this rare genetic disease.
The FDA just approved Denali Therapeutics' new medicine for Hunter syndrome, bringing fresh hope to families affected by this rare genetic disease. The approval comes as a welcome surprise after the agency recently toughened its standards for rare disease treatments.
Families dealing with Hunter syndrome just gained a powerful new treatment option after the FDA granted accelerated approval to Denali Therapeutics' groundbreaking drug. The decision marks a turning point for rare disease patients after a year of tougher regulatory outcomes.
After 20 years without new treatments, the FDA approved Avlayah, the first therapy designed to treat both physical and neurological symptoms of Hunter syndrome. The breakthrough offers hope to families battling this rare disease that causes progressive organ damage and early death.
After 20 years, the FDA approved the first treatment for Hunter syndrome that can prevent brain damage in children. For families watching their kids lose the ability to speak and walk, it's a breakthrough they feared would never come.
Children with Hunter syndrome just got their first new treatment option in nearly two decades. The FDA approved AVLAYAH, a breakthrough therapy from Denali Therapeutics that offers fresh hope to families facing this rare genetic disease.
Children with a rare genetic disorder are developing normally thanks to an enzyme therapy crossing the blood-brain barrier. The FDA could approve the treatment this spring, offering hope to families worldwide.
Researchers at Harvard Medical School have developed a breakthrough gene-editing method that successfully silences the extra chromosome causing Down syndrome in up to 40% of lab cells. While still early stage, this proof-of-concept study opens the door to the first genuine treatment for one of the most common genetic conditions.
Breezy White just became the first person with Down syndrome to graduate from Georgia Highlands College and earn a college degree in Georgia. Her journey from childhood dream to 4.0 GPA student shows what's possible when opportunity meets determination.
A century after his birth, scientist Jérôme Lejeune's breakthrough discovery of Down syndrome's cause now powers a global network helping over 13,000 patients. The foundation bearing his name has become one of the world's leading research centers for genetic intellectual disabilities.
A middle schooler designed a onesie for infants with Down syndrome after watching her brother struggle with regular clothes. Her invention won top prize at Coweta County's Innovation Expo, where 60+ student teams pitched products to solve real problems.
Researchers discovered that different mutations in Rett syndrome require different treatments, opening the door to personalized medicine for children with this developmental disorder. Using advanced brain tissue models, they successfully tested mutation-specific therapies that could help thousands of patients.
A groundbreaking treatment could help children with Dravet syndrome not just reduce seizures, but actually improve cognitive development and daily living skills. For the first time, families facing this devastating genetic condition have hope for a disease-modifying therapy.
Media entrepreneur Chude Jideonwo is breaking silence about living with Tourette syndrome after his doctor warned him not to speak publicly about it. His courage is helping change how neurological conditions are viewed across Africa.
Australian tennis player Storm Hunter won her first-round match just months after tearing her Achilles tendon. The qualifier beat world number 40 Jessica Bouzas Maneiro despite being ranked 327 spots lower.
Scientists at Texas Children's Hospital discovered a promising way to treat Rett syndrome, a rare disorder that affects 1 in 10,000 girls and currently has no cure. The breakthrough could help 65% of patients by boosting levels of a partially working protein in their brains.
Scientists at Texas Children's Hospital discovered a promising way to treat Rett syndrome, a rare disorder affecting 1 in 10,000 girls. The breakthrough could help 65% of patients by boosting levels of a partially working protein in their brains.
Scientists at MIT have discovered what causes leaky blood vessels in children with Rett syndrome and found a way to repair them. The breakthrough points toward potential treatments for a devastating disorder that affects thousands of young girls.
Rory Jaskulski received a newly approved treatment for rare Hunter syndrome just three weeks after FDA approval, transforming his family's outlook from planning a funeral to imagining his future. The New Berlin boy is among the first patients to access a medication the community waited nearly 20 years to see approved.
Scientists at MIT discovered why brain blood vessels become leaky in children with Rett syndrome and found a way to potentially fix it. The breakthrough traces the problem to a single overactive molecule that weakens blood vessel walls.
Showing 20 of 733